机器人辅助与传统二尖瓣修复术的临床效果和成本:全国分析。

IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Annals of Thoracic Surgery Pub Date : 2024-11-11 DOI:10.1016/j.athoracsur.2024.11.005
Joseph Hadaya, Nikhil L Chervu, Shayan Ebrahimian, Yas Sanaiha, Shannon Nesbit, Richard J Shemin, Peyman Benharash
{"title":"机器人辅助与传统二尖瓣修复术的临床效果和成本:全国分析。","authors":"Joseph Hadaya, Nikhil L Chervu, Shayan Ebrahimian, Yas Sanaiha, Shannon Nesbit, Richard J Shemin, Peyman Benharash","doi":"10.1016/j.athoracsur.2024.11.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Robotic approaches have been increasingly utilized for cardiothoracic operations, though concerns regarding costs remain. We evaluated short-term outcomes and costs of robotic-assisted and conventional mitral valve repair (MV-repair), hypothesizing that cost differences would be mitigated at high-volume programs.</p><p><strong>Methods: </strong>Adults undergoing elective MV-repair from 2016 to 2020 were identified in the Nationwide Readmissions Database. Patients with rheumatic heart disease, mitral stenosis, and those undergoing concomitant operations were excluded. Generalized linear models were utilized to evaluate the association between approach and in-hospital mortality, complications, length of stay, costs, and 90-day readmissions. Annual institutional MV-repair volume was modeled using restricted cubic splines, and cost differences subsequently evaluated by volume tertile.</p><p><strong>Results: </strong>Of 40,738 patients, 9.8% underwent robotic-assisted MV-repair. Risk-adjusted outcomes including mortality, stroke, reoperation, respiratory complications, postoperative infection, and readmission were comparable between the two groups, while those undergoing robotic-assisted MV-repair had lower rates of non-home discharge. The median cost of robotic-assisted MV-repair was greater than conventional surgery ($46,800 vs $38,500, p<0.001). Despite a 1.3-day decrement (95% CI 1.1-1.6) in length of stay, robotic-assisted MV-repair was associated with greater risk-adjusted costs by $10,500 (95% CI 5,800-15,200). Programs in the highest volume tertile exhibited comparable costs for robotic-assisted and conventional MV-repair (cost difference $5,900, 95% CI -1,200-12,200, p>0.05).</p><p><strong>Conclusions: </strong>Robotic-assisted MV-repair had comparable short-term outcomes relative to conventional surgery. Despite increased costs of robotic-assisted MV-repair overall, high-volume programs had similar risk-adjusted costs by approach. These findings support the designation and performance of robotic MV-repair at centers of excellence in the United States.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Outcomes and Costs of Robotic-assisted versus Conventional Mitral Valve Repair: A National Analysis.\",\"authors\":\"Joseph Hadaya, Nikhil L Chervu, Shayan Ebrahimian, Yas Sanaiha, Shannon Nesbit, Richard J Shemin, Peyman Benharash\",\"doi\":\"10.1016/j.athoracsur.2024.11.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Robotic approaches have been increasingly utilized for cardiothoracic operations, though concerns regarding costs remain. We evaluated short-term outcomes and costs of robotic-assisted and conventional mitral valve repair (MV-repair), hypothesizing that cost differences would be mitigated at high-volume programs.</p><p><strong>Methods: </strong>Adults undergoing elective MV-repair from 2016 to 2020 were identified in the Nationwide Readmissions Database. Patients with rheumatic heart disease, mitral stenosis, and those undergoing concomitant operations were excluded. Generalized linear models were utilized to evaluate the association between approach and in-hospital mortality, complications, length of stay, costs, and 90-day readmissions. Annual institutional MV-repair volume was modeled using restricted cubic splines, and cost differences subsequently evaluated by volume tertile.</p><p><strong>Results: </strong>Of 40,738 patients, 9.8% underwent robotic-assisted MV-repair. Risk-adjusted outcomes including mortality, stroke, reoperation, respiratory complications, postoperative infection, and readmission were comparable between the two groups, while those undergoing robotic-assisted MV-repair had lower rates of non-home discharge. The median cost of robotic-assisted MV-repair was greater than conventional surgery ($46,800 vs $38,500, p<0.001). Despite a 1.3-day decrement (95% CI 1.1-1.6) in length of stay, robotic-assisted MV-repair was associated with greater risk-adjusted costs by $10,500 (95% CI 5,800-15,200). Programs in the highest volume tertile exhibited comparable costs for robotic-assisted and conventional MV-repair (cost difference $5,900, 95% CI -1,200-12,200, p>0.05).</p><p><strong>Conclusions: </strong>Robotic-assisted MV-repair had comparable short-term outcomes relative to conventional surgery. Despite increased costs of robotic-assisted MV-repair overall, high-volume programs had similar risk-adjusted costs by approach. These findings support the designation and performance of robotic MV-repair at centers of excellence in the United States.</p>\",\"PeriodicalId\":50976,\"journal\":{\"name\":\"Annals of Thoracic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Thoracic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.athoracsur.2024.11.005\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Thoracic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.athoracsur.2024.11.005","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:心胸外科手术越来越多地采用机器人方法,但成本问题仍令人担忧。我们对机器人辅助和传统二尖瓣修复术(MV-repair)的短期疗效和成本进行了评估,并假设高容量项目的成本差异将得到缓解:从全国再入院数据库(Nationalwide Readmissions Database)中筛选出2016年至2020年期间接受择期二尖瓣修复术的成年人。排除了风湿性心脏病、二尖瓣狭窄和同时接受手术的患者。利用广义线性模型评估了手术方式与院内死亡率、并发症、住院时间、费用和 90 天再入院率之间的关系。使用限制性立方样条对医院每年的中风修复量进行建模,然后按修复量三等分评估成本差异:结果:在 40738 名患者中,9.8% 接受了机器人辅助中风修复术。经风险调整后,两组患者的死亡率、中风、再次手术、呼吸系统并发症、术后感染和再次入院率相当,而接受机器人辅助中风修复术的患者非居家出院率较低。机器人辅助中压修复术的中位成本高于传统手术(46,800 美元对 38,500 美元,P0.05):结论:与传统手术相比,机器人辅助中风修复术的短期疗效相当。尽管机器人辅助中压修复术的总体成本增加,但高容量项目的风险调整成本与传统手术相似。这些研究结果支持在美国卓越中心指定并实施机器人中风修复术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinical Outcomes and Costs of Robotic-assisted versus Conventional Mitral Valve Repair: A National Analysis.

Background: Robotic approaches have been increasingly utilized for cardiothoracic operations, though concerns regarding costs remain. We evaluated short-term outcomes and costs of robotic-assisted and conventional mitral valve repair (MV-repair), hypothesizing that cost differences would be mitigated at high-volume programs.

Methods: Adults undergoing elective MV-repair from 2016 to 2020 were identified in the Nationwide Readmissions Database. Patients with rheumatic heart disease, mitral stenosis, and those undergoing concomitant operations were excluded. Generalized linear models were utilized to evaluate the association between approach and in-hospital mortality, complications, length of stay, costs, and 90-day readmissions. Annual institutional MV-repair volume was modeled using restricted cubic splines, and cost differences subsequently evaluated by volume tertile.

Results: Of 40,738 patients, 9.8% underwent robotic-assisted MV-repair. Risk-adjusted outcomes including mortality, stroke, reoperation, respiratory complications, postoperative infection, and readmission were comparable between the two groups, while those undergoing robotic-assisted MV-repair had lower rates of non-home discharge. The median cost of robotic-assisted MV-repair was greater than conventional surgery ($46,800 vs $38,500, p<0.001). Despite a 1.3-day decrement (95% CI 1.1-1.6) in length of stay, robotic-assisted MV-repair was associated with greater risk-adjusted costs by $10,500 (95% CI 5,800-15,200). Programs in the highest volume tertile exhibited comparable costs for robotic-assisted and conventional MV-repair (cost difference $5,900, 95% CI -1,200-12,200, p>0.05).

Conclusions: Robotic-assisted MV-repair had comparable short-term outcomes relative to conventional surgery. Despite increased costs of robotic-assisted MV-repair overall, high-volume programs had similar risk-adjusted costs by approach. These findings support the designation and performance of robotic MV-repair at centers of excellence in the United States.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Thoracic Surgery
Annals of Thoracic Surgery 医学-呼吸系统
CiteScore
6.40
自引率
13.00%
发文量
1235
审稿时长
42 days
期刊介绍: The mission of The Annals of Thoracic Surgery is to promote scholarship in cardiothoracic surgery patient care, clinical practice, research, education, and policy. As the official journal of two of the largest American associations in its specialty, this leading monthly enjoys outstanding editorial leadership and maintains rigorous selection standards. The Annals of Thoracic Surgery features: • Full-length original articles on clinical advances, current surgical methods, and controversial topics and techniques • New Technology articles • Case reports • "How-to-do-it" features • Reviews of current literature • Supplements on symposia • Commentary pieces and correspondence • CME • Online-only case reports, "how-to-do-its", and images in cardiothoracic surgery. An authoritative, clinically oriented, comprehensive resource, The Annals of Thoracic Surgery is committed to providing a place for all thoracic surgeons to relate experiences which will help improve patient care.
期刊最新文献
Ex Vivo Lung Perfusion in Donation after Cardiac and Brain Death Donation. Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2cm? Sequential Grafting of the Left Internal Thoracic Artery to the Left Anterior Descending Artery and Graft Failure. Clinical Outcomes and Costs of Robotic-assisted versus Conventional Mitral Valve Repair: A National Analysis. Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1